FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Richard Gelber

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Physiology

Co-author Network

Publications

TOP 3
Viviana Galimberti; Jean-Rémi Garbay; Richard D Gelber; Oreste Gentilini; Aron Goldhirsch; Mattia Intra; David Littlejohn; Alberto Luini; Samuele Massarut; Mauro Mastropasqua; Giovanni Mazzarol; Karen N Price; Angelo Recalcati; Meredith M Regan; Manuela Sargenti; Paolo Veronesi; Umberto Veronesi; Giuseppe Viale; Janez Zgajnar; Stefano Zurrida; Monika Bamert; Paola Baratella; Camelia Chifu; Alan S Coates; Bernard F Cole; Marco Colleoni; Hanne Galatius
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.
Diana Crivellari; Silvia Dellapasqua; Richard D Gelber; Lorenzo Gianni; Aron Goldhirsch; Kathryn P Gray; István Láng; Jean-Marc Lüthi; Rudolf Maibach; Graziella Pinotti; Karen N Price; Fabio Puglisi; Manuela Rabaglio; Meredith M Regan; Karin Ribi; Simon Spazzapan; Monica Castiglione-Gertsch; Alan S Coates; Marco Colleoni
Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a "standard chemotherapy regimen": the CASA randomized trial.
Bernhard C Pestalozzi; Martine J Piccart-Gebhart; Roberto I Lopez Sanchez; Matt Scullion; Andrew Wardley; Evandro de Azambuja; David Dodwell; Richard D Gelber; Laurence Hogge; Eileen Holmes; István Láng; Mikhail Lichinitser; Otto Metzger-Filho; Volkmar Müller; David Cameron
CNS relapses in patients with HER2-positive early breast cancer who have and have not received adjuvant trastuzumab: a retrospective substudy of the HERA trial (BIG 1-01).

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Richard Gelber (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Viviana Galimberti; Jean-Rémi Garbay; Richard D Gelber; Oreste Gentilini; Aron Goldhirsch; Mattia Intra; David Littlejohn; Alberto Luini; Samuele Massarut; Mauro Mastropasqua; Giovanni Mazzarol; Karen N Price; Angelo Recalcati; Meredith M Regan; Manuela Sargenti; Paolo Veronesi; Umberto Veronesi; Giuseppe Viale; Janez Zgajnar; Stefano Zurrida; Monika Bamert; Paola Baratella; Camelia Chifu; Alan S Coates; Bernard F Cole; Marco Colleoni; Hanne Galatius
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.
The lancet oncology 2013;14(4):297-305.
2013: Diana Crivellari; Silvia Dellapasqua; Richard D Gelber; Lorenzo Gianni; Aron Goldhirsch; Kathryn P Gray; István Láng; Jean-Marc Lüthi; Rudolf Maibach; Graziella Pinotti; Karen N Price; Fabio Puglisi; Manuela Rabaglio; Meredith M Regan; Karin Ribi; Simon Spazzapan; Monica Castiglione-Gertsch; Alan S Coates; Marco Colleoni
Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a "standard chemotherapy regimen": the CASA randomized trial.
Breast (Edinburgh, Scotland) 2013;22(2):130-7.
2013: Bernhard C Pestalozzi; Martine J Piccart-Gebhart; Roberto I Lopez Sanchez; Matt Scullion; Andrew Wardley; Evandro de Azambuja; David Dodwell; Richard D Gelber; Laurence Hogge; Eileen Holmes; István Láng; Mikhail Lichinitser; Otto Metzger-Filho; Volkmar Müller; David Cameron
CNS relapses in patients with HER2-positive early breast cancer who have and have not received adjuvant trastuzumab: a retrospective substudy of the HERA trial (BIG 1-01).
The lancet oncology 2013;14(3):244-8.
2012: Marianne Ewertz; John Forbes; Richard D Gelber; Aron Goldhirsch; Kathryn P Gray; István Láng; Hervé Bonnefoi; Alan S Coates; Marco Colleoni; Bent Ejlertsen; Robert Paridaens; Karen N Price; Manuela Rabaglio; Meredith M Regan; Ian E Smith; Beat Thürlimann; Henning T Mouridsen
Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1-98 trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(32):3967-75.
2012: P Karlsson; A Kovács; Jurij Lindtner; Karen N Price; B Thürlimann; Monica Castiglione-Gertsch; B H Chua; B F Cole; J P Collins; Diana Crivellari; J F Forbes; Richard D Gelber; Aron Goldhirsch; G Gruber
Patterns and risk factors for locoregional failures after mastectomy for breast cancer: an International Breast Cancer Study Group report.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(11):2852-8.
2012: Aron Goldhirsch; Richard D Gelber
Breast cancer: Anastrozole and fulvestrant--combination to unlock efficacy.
Nature reviews. Clinical oncology 2012;9(10):556-7.
2012: Silvia Dellapasqua; Richard D Gelber; Aron Goldhirsch; Eugenio Maiorano; Mauro Mastropasqua; Karen N Price; Meredith M Regan; Nicole Rotmensz; Giuseppe Viale; Vincenzo Bagnardi; Monica Castiglione-Gertsch; Marco Colleoni
A risk score based on histopathological features predicts higher risk of distant recurrence in premenopausal patients with lymph node-negative endocrine-responsive breast cancer.
Breast (Edinburgh, Scotland) 2012;21(5):621-8.
2012: Bent Ejlertsen; Richard D Gelber; K L Henriksen; A E Lykkesfeldt; H Mouridsen; S Müller; K V Nielsen; Karen N Price; B B Rasmussen; M M Regan; G Viale; J Aldridge
Prognostic and predictive role of ESR1 status for postmenopausal patients with endocrine-responsive early breast cancer in the Danish cohort of the BIG 1-98 trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(5):1138-44.
2012: Meredith M Regan; Weining Tang; Beat Thürlimann; Giuseppe Viale; Maria Olivia Biasi; Mark Bouzyk; Alan Coates; Marc Debled; Patrizia Dell'Orto; Henrik J Ditzel; Richard D Gelber; Aron Goldhirsch; Roswitha Kammler; Brian Leyland-Jones; Maria B Lyng; Rudolf Maibach; Patrick Neven; Olivia Pagani; Karen N Price; James M Rae
CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the breast international group 1-98 trial.
Journal of the National Cancer Institute 2012;104(6):441-51.
2011: Meredith M Regan; Ian Smith; Beat Thürlimann; Andrew Wardley; Alan Coates; Bent Ejlertsen; John Forbes; Richard D Gelber; Anita Giobbie-Hurder; Aron Goldhirsch; István Láng; Louis Mauriac; Patrick Neven; Karen N Price; Manuela Rabaglio
Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up.
The lancet oncology 2011;12(12):1101-8.
2011: P Karlsson; Elizabeth Margaret Murray; Karen N Price; Manuela Rabaglio; M M Regan; Zhuoxin Sun; Giuseppe Viale; K Zaman; D Braun; Monica Castiglione-Gertsch; Alan Coates; Marco Colleoni; J Collins; Diana Crivellari; Richard D Gelber; B A Gusterson; Aron Goldhirsch
Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(10):2216-26.
2011: Stefan Aebi; D Braun; Monica Castiglione-Gertsch; Alan Coates; Diana Crivellari; Richard D Gelber; B A Gusterson; P Karlsson; Jurij Lindtner; Karen N Price; Manuela Rabaglio; M M Regan; Edda Simoncini; R Snyder; Zhuoxin Sun; Giuseppe Viale; Aron Goldhirsch
Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: long-term follow up on IBCSG Trial IX.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(9):1981-7.
2011: Aron Goldhirsch; Hans-Jörg Senn; Beat Thürlimann; W C Wood; Alan Coates; Richard D Gelber
Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(8):1736-47.
2011: Marco Colleoni; Anita Giobbie-Hurder; Meredith M Regan; Beat Thürlimann; Henning Mouridsen; Louis Mauriac; John F Forbes; Robert Paridaens; István Láng; Ian Smith; Jacquie Chirgwin; Tadeusz Pienkowski; Andrew Wardley; Karen N Price; Richard D Gelber; Alan S Coates; Aron Goldhirsch
Analyses adjusting for selective crossover show improved overall survival with adjuvant letrozole compared with tamoxifen in the BIG 1-98 study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(9):1117-24.
2010: Ann A Lazar; Bernard F Cole; Marco Bonetti; Richard D Gelber
Evaluation of treatment-effect heterogeneity using biomarkers measured on a continuous scale: subpopulation treatment effect pattern plot.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(29):4539-44.
2010: Katrín A Gunnarsdóttir; Maj-Britt Jensen; David Zahrieh; Richard D Gelber; Ann Knoop; Marco Bonetti; Henning Mouridsen; Bent Ejlertsen
CEF is superior to CMF for tumours with TOP2A aberrations: a Subpopulation Treatment Effect Pattern Plot (STEPP) analysis on Danish Breast Cancer Cooperative Group Study 89D.
Breast cancer research and treatment 2010;123(1):163-9.
2010: Marco Colleoni; Bernard F Cole; Giuseppe Viale; Meredith M Regan; Karen N Price; Eugenio Maiorano; Mauro Mastropasqua; Diana Crivellari; Richard D Gelber; Aron Goldhirsch; Alan Coates; Barry A Gusterson
Classical cyclophosphamide, methotrexate, and fluorouracil chemotherapy is more effective in triple-negative, node-negative breast cancer: results from two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(18):2966-73.
2010: Giuseppe Viale; Anita Giobbie-Hurder; Barry A Gusterson; Eugenio Maiorano; Mauro Mastropasqua; A Sonzogni; E Mallon; Marco Colleoni; Monica Castiglione-Gertsch; Meredith M Regan; Karen N Price; R W Brown; Rastko Golouh; D Crivellari; P Karlsson; C Ohlschlegel; Richard D Gelber; Aron Goldhirsch; Alan Coates
Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(2):245-54.
2010: Evandro de Azambuja; Worta McCaskill-Stevens; Prudence Francis; Emmanuel Quinaux; John Crown; Malou Vicente; Rosa Giuliani; Bo Nordenskjöld; Jorge Gutiérez; Michael Andersson; Mireia Margeli Vila; Raimund Jakesz; Jan Demol; Joanna Dewar; Armando Santoro; Ana Lluch; Steven Olsen; Richard D Gelber; Angelo Di Leo; Martine J Piccart-Gebhart
The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial.
Breast cancer research and treatment 2010;119(1):145-53.
2009: Richard D Gelber; Shari Gelber
Facilitating consensus by examining patterns of treatment effects.
Breast (Edinburgh, Scotland) 2009;18 Suppl 3():S2-8.
2009: M Rabaglio; Z Sun; Karen N Price; Monica Castiglione-Gertsch; H Hawle; Beat Thürlimann; H Mouridsen; M Campone; J F Forbes; R J Paridaens; Marco Colleoni; T Pienkowski; J-M Nogaret; I Láng; I Smith; Richard D Gelber; Aron Goldhirsch; Alan Coates
Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(9):1489-98.
2009: Olivia Pagani; Karen N Price; Richard D Gelber; Monica Castiglione-Gertsch; Stig B Holmberg; Jurij Lindtner; Beat Thürlimann; John Collins; Martin F Fey; Alan Coates; Aron Goldhirsch
Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century.
Breast cancer research and treatment 2009;117(2):319-24.
2009: Aron Goldhirsch; J N Ingle; Richard D Gelber; Alan Coates; Beat Thürlimann; Hans-Jörg Senn
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(8):1319-29.
2009: Marco Colleoni; Z Sun; Giovanni Martinelli; R L Basser; Alan Coates; Richard D Gelber; M D Green; Fedro Alessandro Peccatori; Saverio Cinieri; Stefan Aebi; Giuseppe Viale; Karen N Price; Aron Goldhirsch
The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(8):1344-51.
2009: Olivia Pagani; Shari Gelber; Edda Simoncini; Monica Castiglione-Gertsch; Karen N Price; Richard D Gelber; Stig B Holmberg; Diana Crivellari; John Collins; Jurij Lindtner; Beat Thürlimann; Martin F Fey; Elizabeth Margaret Murray; John Forbes; Alan Coates; Aron Goldhirsch
Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93.
Breast cancer research and treatment 2009;116(3):491-500.
2009: Marco Colleoni; Vincenzo Bagnardi; Nicole Rotmensz; Richard D Gelber; Giuseppe Viale; Giancarlo Pruneri; Paolo Veronesi; Rosalba Torrisi; Anna Cardillo; Emilia Montagna; Elisabetta Campagnoli; Alberto Luini; Mattia Intra; Viviana Galimberti; Eloise Scarano; Giulia Peruzzotti; Aron Goldhirsch
Increasing steroid hormone receptors expression defines breast cancer subtypes non responsive to preoperative chemotherapy.
Breast cancer research and treatment 2009;116(2):359-69.
2009: Mitch Dowsett; Marion Procter; Worta McCaskill-Stevens; Evandro de Azambuja; Urania Dafni; Josef Rueschoff; Bruce Jordan; Stella Dolci; Mark Abramovitz; Oliver Stoss; Giuseppe Viale; Richard D Gelber; Martine J Piccart-Gebhart; Brian Leyland-Jones
Disease-free survival according to degree of HER2 amplification for patients treated with adjuvant chemotherapy with or without 1 year of trastuzumab: the HERA Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(18):2962-9.
2009: Anita Giobbie-Hurder; Karen N Price; Richard D Gelber
Design, conduct, and analyses of Breast International Group (BIG) 1-98: a randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer.
Clinical trials (London, England) 2009;6(3):272-87.
2009: Zhuoxin Sun; Aron Goldhirsch; Karen N Price; Marco Colleoni; Alberto Ravaioli; Edda Simoncini; Ian Campbell; Richard D Gelber; Mark Towler
Bone Quality Test (BQT) scores of fingernails in postmenopausal patients treated with adjuvant letrozole or tamoxifen for early breast cancer.
Breast (Edinburgh, Scotland) 2009;18(2):84-8.
2009: Christine Desmedt; Anita Giobbie-Hurder; Patrick Neven; Robert Paridaens; Marie-Rose Christiaens; Ann Smeets; Françoise Lallemand; Benjamin Haibe-Kains; Giuseppe Viale; Richard D Gelber; Martine Piccart; Christos Sotiriou
The Gene expression Grade Index: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial.
BMC medical genomics 2009;2():40.
2008: Giuseppe Viale; Anita Giobbie-Hurder; Meredith M Regan; Alan Coates; Mauro Mastropasqua; Patrizia Dell'Orto; Eugenio Maiorano; gaetan macgrogan; Stephen G Braye; Christian Ohlschlegel; Patrick Neven; Orosz Zsolt; Wojciech P Olszewski; Fiona Knox; Beat Thürlimann; Karen N Price; Monica Castiglione-Gertsch; Richard D Gelber; Barry A Gusterson; Aron Goldhirsch
Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(34):5569-75.
2008: Bernhard C Pestalozzi; P Francis; E Quinaux; S Dolci; E Azambuja; Richard D Gelber; Giuseppe Viale; A Balil; Michael Andersson; Bo Nordenskjöld; M Gnant; J Gutierrez; I Láng; J P A Crown; M Piccart-Gebhart
Is risk of central nervous system (CNS) relapse related to adjuvant taxane treatment in node-positive breast cancer? Results of the CNS substudy in the intergroup Phase III BIG 02-98 Trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(11):1837-41.
2008: James Robert Anderson; Kevin C Cain; Richard D Gelber
Analysis of survival by tumor response and other comparisons of time-to-event by outcome variables.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(24):3913-5.
2008: Marco Bonetti; Bernard F Cole; Richard D Gelber
Another STEPP in the right direction.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(22):3813-4; author reply 3814-5.
2008: G Gruber; B F Cole; M Castiglione-Gertsch; S B Holmberg; J Lindtner; R Golouh; J Collins; D Crivellari; B Thürlimann; E Simoncini; M F Fey; Richard D Gelber; Alan Coates; K N Price; A Goldhirsch; Giuseppe Viale; barry gusterson
Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(8):1393-401.
2008: Meredith M Regan; O Pagani; B Walley; R Torrisi; E A Perez; P Francis; G F Fleming; K N Price; B Thürlimann; R Maibach; M Castiglione-Gertsch; Alan Coates; A Goldhirsch; Richard D Gelber
Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(7):1231-41.
2008: Bernhard C Pestalozzi; David Zahrieh; Elizabeth Mallon; Barry A Gusterson; Karen N Price; Richard D Gelber; Stig B Holmberg; Jurij Lindtner; Raymond Snyder; Beat Thürlimann; Elizabeth Margaret Murray; Giuseppe Viale; Monica Castiglione-Gertsch; Alan Coates; Aron Goldhirsch
Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(18):3006-14.
2008: Irene L Wapnir; Stefan Aebi; Charles E Geyer; David Zahrieh; Richard D Gelber; Stewart J Anderson; Andre Robidoux; Jürg Bernhard; Rudolf Maibach; Monica Castiglione-Gertsch; Alan Coates; Martine J Piccart; Mark J Clemons; Joseph P Costantino; Norman Wolmark
A randomized clinical trial of adjuvant chemotherapy for radically resected locoregional relapse of breast cancer: IBCSG 27-02, BIG 1-02, and NSABP B-37.
Clinical breast cancer 2008;8(3):287-92.
2008: Michael Untch; Richard D Gelber; C Jackisch; M Procter; J Baselga; R Bell; D Cameron; M Bari; I Smith; Brian Leyland-Jones; E de Azambuja; P Wermuth; R Khasanov; F Feng-Yi; C Constantin; J I Mayordomo; C-H Su; S-Y Yu; A Lluch; E Senkus-Konefka; C Price; F Haslbauer; T Suarez Sahui; V Srimuninnimit; M Colleoni; Alan Coates; M J Piccart-Gebhart; A Goldhirsch
Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(6):1090-6.
2008: Andrea Rocca; Giuseppe Viale; Richard D Gelber; Luca Bottiglieri; Shari Gelber; Giancarlo Pruneri; Raffaella Ghisini; Alessandra Balduzzi; Elisabetta Pietri; Claudia D'Alessandro; Aron Goldhirsch; Marco Colleoni
Pathologic complete remission rate after cisplatin-based primary chemotherapy in breast cancer: correlation with p63 expression.
Cancer chemotherapy and pharmacology 2008;61(6):965-71.
2008: Diana Crivellari; Zhuoxin Sun; Alan Coates; Karen N Price; Beat Thürlimann; Henning Mouridsen; Louis Mauriac; John Forbes; Robert Paridaens; Monica Castiglione-Gertsch; Richard D Gelber; Marco Colleoni; István Láng; Lucia Del Mastro; Laurence Gladieff; Manuela Rabaglio; Ian E Smith; Jacquie H Chirgwin; Aron Goldhirsch
Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: the BIG 1-98 trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(12):1972-9.
2008: Giuseppe Viale; Meredith M Regan; Eugenio Maiorano; Mauro Mastropasqua; Rastko Golouh; Tiziana Perin; Robert W Brown; Anikó Kovács; Komala Pillay; Christian Ohlschlegel; Stephen Braye; Piergiovanni Grigolato; Tiziana Rusca; Richard D Gelber; Monica Castiglione-Gertsch; Karen N Price; Aron Goldhirsch; Barry A Gusterson; Alan Coates
Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(9):1404-10.
2008: Marco Colleoni; Giuseppe Viale; David Zahrieh; L Bottiglieri; Richard D Gelber; Paolo Veronesi; Alessandra Balduzzi; Rosalba Torrisi; Alberto Luini; Mattia Intra; Silvia Dellapasqua; Anna Cardillo; Raffaella Ghisini; Giulia Peruzzotti; Aron Goldhirsch
Expression of ER, PgR, HER1, HER2, and response: a study of preoperative chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(3):465-72.
2008: Giuseppe Viale; Meredith M Regan; Mauro Mastropasqua; Fausto Antonio Maffini; Eugenio Maiorano; Marco Colleoni; Karen N Price; Rastko Golouh; Tiziana Perin; R W Brown; Anikó Kovács; Komala Pillay; Christian Ohlschlegel; Barry A Gusterson; Monica Castiglione-Gertsch; Richard D Gelber; Aron Goldhirsch; Alan Coates
Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.
Journal of the National Cancer Institute 2008;100(3):207-12.
2008: P Francis; John Crown; Angelo Di Leo; Marc Buyse; Ana Balil; Michael Andersson; Bo Nordenskjöld; Istvan Lang; Raimund Jakesz; Daniel Vorobiof; Jorge Gutiérrez; Guy Van Hazel; Stella Dolci; Sophie Jamin; Belguendouz Bendahmane; Richard D Gelber; Aron Goldhirsch; Monica Castiglione-Gertsch; Martine Piccart-Gebhart
Adjuvant chemotherapy with sequential or concurrent anthracycline and docetaxel: Breast International Group 02-98 randomized trial.
Journal of the National Cancer Institute 2008;100(2):121-33.
2008: Jürg Bernhard; David Zahrieh; J J Zhang; G Martinelli; R Basser; Christoph Hürny; John Forbes; Stefan Aebi; W Yeo; Beat Thürlimann; M D Green; Marco Colleoni; Richard D Gelber; Monica Castiglione-Gertsch; Karen N Price; Aron Goldhirsch; Alan Coates
Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer.
British journal of cancer 2008;98(1):25-33.
2008: Mike Clarke; Alan Coates; Sarah C Darby; C Davies; Richard D Gelber; Jon Godwin; A Goldhirsch; R Gray; R Peto; K I Pritchard; W C Wood
Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials.
Lancet 2008;371(9606):29-40.
2008: Birgitte B Rasmussen; Meredith M Regan; Anne E Lykkesfeldt; Patrizia Dell'Orto; Barbara Del Curto; Katrine L Henriksen; Mauro Mastropasqua; Karen N Price; Eliane Méry; Magali Lacroix-Triki; Stephen Braye; Hans J Altermatt; Richard D Gelber; Monica Castiglione-Gertsch; Aron Goldhirsch; Barry A Gusterson; Beat Thürlimann; Alan Coates; Giuseppe Viale
Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial.
The lancet oncology 2008;9(1):23-8.
2007: Henning Mouridsen; Aparna Keshaviah; Alan Coates; Manuela Rabaglio; Monica Castiglione-Gertsch; Zhuoxin Sun; Beat Thürlimann; Louis Mauriac; John Forbes; Robert Paridaens; Richard D Gelber; Marco Colleoni; Ian Smith; Karen N Price; Aron Goldhirsch
Cardiovascular adverse events during adjuvant endocrine therapy for early breast cancer using letrozole or tamoxifen: safety analysis of BIG 1-98 trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(36):5715-22.
2007: Meredith M Regan; Richard D Gelber
Using clinical trial data to tailor adjuvant treatments for individual patients.
Breast (Edinburgh, Scotland) 2007;16 Suppl 2():S98-104.
2007: Giuseppe Viale; Meredith M Regan; Eugenio Maiorano; Mauro Mastropasqua; Patrizia Dell'Orto; Birgitte Bruun Rasmussen; Johnny Raffoul; Patrick Neven; Orosz Zsolt; Stephen Braye; Christian Ohlschlegel; Beat Thürlimann; Richard D Gelber; Monica Castiglione-Gertsch; Karen N Price; Aron Goldhirsch; Barry A Gusterson; Alan Coates
Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(25):3846-52.
2007: Thomas M Suter; Marion Procter; Dirk J van Veldhuisen; Michael Muscholl; Jonas Bergh; Chiara Carlomagno; Timothy Perren; Rodolfo Passalacqua; Claudia Bighin; Jan G M Klijn; Fail T Ageev; Erika Hitre; Juergen Groetz; Hiroji Iwata; Malgorzata Knap; Michael Gnant; Susanne Muehlbauer; Alison Spence; Richard D Gelber; Martine J Piccart-Gebhart
Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(25):3859-65.
2007: Aron Goldhirsch; William C Wood; Richard D Gelber; Alan Coates; Beat Thürlimann; Hans-Jörg Senn
Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(7):1133-44.
2007: Ann H Partridge; Shari Gelber; Richard D Gelber; Monica Castiglione-Gertsch; Aron Goldhirsch; Eric P Winer
Age of menopause among women who remain premenopausal following treatment for early breast cancer: long-term results from International Breast Cancer Study Group Trials V and VI.
European journal of cancer (Oxford, England : 1990) 2007;43(11):1646-53.
2007: Marco Colleoni; Shari Gelber; Edda Simoncini; Olivia Pagani; Richard D Gelber; Karen N Price; Monica Castiglione-Gertsch; Alan Coates; Aron Goldhirsch
Effects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(7):1177-84.
2007: Clifford Hudis; William E Barlow; Joseph P Costantino; Robert J Gray; Kathleen I Pritchard; Judith-Anne W Chapman; Joseph A Sparano; Sally Hunsberger; Rebecca A Enos; Richard D Gelber; Jo Anne Zujewski
Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(15):2127-32.
2007: V Craig Jordan; Richard D Gelber
Problems with the progesterone receptor in practice?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(15):1957-9.
2007: Per Karlsson; Bernard F Cole; Karen N Price; Alan Coates; Monica Castiglione-Gertsch; Barry A Gusterson; Elizabeth Margaret Murray; Jurij Lindtner; John P Collins; Stig B Holmberg; Martin F Fey; Beat Thürlimann; Diana Crivellari; John Forbes; Richard D Gelber; Aron Goldhirsch; Arne Wallgren
The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(15):2019-26.
2007: Louis Mauriac; Aparna Keshaviah; Marc Debled; Henning Mouridsen; John Forbes; Beat Thürlimann; Robert Paridaens; A Monnier; I Láng; Andrew Wardley; Jean-Marie Nogaret; Richard D Gelber; Monica Castiglione-Gertsch; Karen N Price; Alan Coates; Ian Smith; Giuseppe Viale; Manuela Rabaglio; N Zabaznyi; Aron Goldhirsch
Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(5):859-67.
2007: Aparna Keshaviah; Silvia Dellapasqua; N Rotmensz; Jurij Lindtner; Diana Crivellari; John Collins; Marco Colleoni; Beat Thürlimann; Caesar Mendiola; Stefan Aebi; Karen N Price; Olivia Pagani; Edda Simoncini; Monica Castiglione-Gertsch; Richard D Gelber; Alan Coates; Aron Goldhirsch
CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(4):701-8.
2007: Alan Coates; Aparna Keshaviah; Beat Thürlimann; Henning Mouridsen; Louis Mauriac; John Forbes; Robert Paridaens; Monica Castiglione-Gertsch; Richard D Gelber; Marco Colleoni; István Láng; Lucia Del Mastro; Ian Smith; Jacquie Chirgwin; Jean-Marie Nogaret; Tadeusz Pienkowski; Andrew Wardley; Erik H Jakobsen; Karen N Price; Aron Goldhirsch
Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(5):486-92.
2007: Albert Moghrabi; Donna E Levy; Barbara L Asselin; Ronald Barr; Luis A Clavell; Craig A Hurwitz; Yvan Samson; Marshall Schorin; Virginia Dalton; Steven E Lipshultz; Donna Neuberg; Richard D Gelber; Harvey Jay Cohen; Stephen E Sallan; Lewis B Silverman
Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia.
Blood 2007;109(3):896-904.
2007: Jürg Bernhard; David Zahrieh; Monica Castiglione-Gertsch; Christoph Hürny; Richard D Gelber; John Forbes; Elizabeth Margaret Murray; John Collins; Stefan Aebi; Beat Thürlimann; Karen N Price; Aron Goldhirsch; Alan Coates
Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIII.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(3):263-70.
2007: Ian Smith; Marion Procter; Richard D Gelber; Sébastien Guillaume; Andrea Feyereislova; Mitch Dowsett; Aron Goldhirsch; Michael Untch; Gabriella Mariani; José Baselga; Manfred Kaufmann; David Cameron; Richard Bell; Jonas Bergh; Robert Coleman; Andrew Wardley; Nadia Harbeck; Roberto I Lopez; Peter Mallmann; Karen Gelmon; Nicholas Wilcken; Erik Wist; Pedro Sánchez-Rovira; Martine J Piccart-Gebhart
2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial.
Lancet 2007;369(9555):29-36.
2006: Aron Goldhirsch; Alan Coates; Richard D Gelber; JH Glick; Beat Thürlimann; Hans-Jörg Senn
First--select the target: better choice of adjuvant treatments for breast cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(12):1772-6.
2006: Meredith M Regan; Giuseppe Viale; Mauro Mastropasqua; Eugenio Maiorano; Rastko Golouh; Antonino Carbone; Bob Brown; Mart Suurküla; Gerald Langman; Luca Mazzucchelli; Stephen Braye; Piergiovanni Grigolato; Richard D Gelber; Monica Castiglione-Gertsch; Karen N Price; Alan Coates; Aron Goldhirsch; Barry A Gusterson
Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
Journal of the National Cancer Institute 2006;98(21):1571-81.
2006: Bernhard C Pestalozzi; David Zahrieh; Karen N Price; Stig B Holmberg; Jurij Lindtner; John Collins; Diana Crivellari; Martin F Fey; Elizabeth Margaret Murray; Olivia Pagani; Edda Simoncini; Monica Castiglione-Gertsch; Richard D Gelber; Alan Coates; Aron Goldhirsch
Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(6):935-44.
2006: Marco Colleoni; Shari Gelber; Aron Goldhirsch; Stefan Aebi; Monica Castiglione-Gertsch; Karen N Price; Alan Coates; Richard D Gelber
Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13-93.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(9):1332-41.
2006: Lorenzo Gianni; Ilaria Panzini; Sigui Li; Richard D Gelber; John Collins; Stig B Holmberg; Diana Crivellari; Monica Castiglione-Gertsch; Aron Goldhirsch; Alan Coates; Alberto Ravaioli
Ocular toxicity during adjuvant chemoendocrine therapy for early breast cancer: results from International Breast Cancer Study Group trials.
Cancer 2006;106(3):505-13.
2006: Russell L Basser; Anne O'Neill; Giovanni Martinelli; Michael D Green; Fedro Alessandro Peccatori; Saverio Cinieri; Alan Coates; Richard D Gelber; Stefan Aebi; Monica Castiglione-Gertsch; Giuseppe Viale; Karen N Price; Aron Goldhirsch
Multicycle dose-intensive chemotherapy for women with high-risk primary breast cancer: results of International Breast Cancer Study Group Trial 15-95.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(3):370-8.
2006: Carl-Magnus Rudenstam; David Zahrieh; John Forbes; Diana Crivellari; Stig B Holmberg; Piercarlo Rey; David Dent; Ian Campbell; Jürg Bernhard; Karen N Price; Monica Castiglione-Gertsch; Aron Goldhirsch; Richard D Gelber; Alan S Coates
Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(3):337-44.
2005: Beat Thürlimann; Aparna Keshaviah; Alan Coates; Henning Mouridsen; Louis Mauriac; John Forbes; Robert Paridaens; Monica Castiglione-Gertsch; Richard D Gelber; Manuela Rabaglio; Ian Smith; Andrew Wardley; Andrew Wardly; Karen N Price; Aron Goldhirsch
A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer.
The New England journal of medicine 2005;353(26):2747-57.
2005: Meredith M Regan; Richard D Gelber
Predicting response to systemic treatments: learning from the past to plan for the future.
Breast (Edinburgh, Scotland) 2005;14(6):582-93.
2005: Martine J Piccart-Gebhart; Marion Procter; Brian Leyland-Jones; Aron Goldhirsch; Michael Untch; Ian Smith; Luca Gianni; Jose Baselga; Richard Bell; Christian Jackisch; David Cameron; Mitch Dowsett; Carlos H Barrios; Günther Steger; Chiun-Shen Huang; Michael Andersson; Moshe Inbar; Mikhail Lichinitser; István Láng; Ulrike Nitz; Hiroji Iwata; Christoph Thomssen; Caroline Lohrisch; Thomas M Suter; Josef Rüschoff; Tamás Suto; Victoria Greatorex; Carol Ward; Carolyn Straehle; Eleanor McFadden; M Stella Dolci; Richard D Gelber
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.
The New England journal of medicine 2005;353(16):1659-72.
2005: Günther Gruber; Marco Bonetti; M Laura Nasi; Karen N Price; Monica Castiglione-Gertsch; Carl-Magnus Rudenstam; Stig B Holmberg; Jurij Lindtner; Rastko Golouh; John Collins; Diana Crivellari; Antonino Carbone; Beat Thürlimann; Edda Simoncini; Martin F Fey; Richard D Gelber; Alan Coates; Aron Goldhirsch
Prognostic value of extracapsular tumor spread for locoregional control in premenopausal patients with node-positive breast cancer treated with classical cyclophosphamide, methotrexate, and fluorouracil: long-term observations from International Breast Cancer Study Group Trial VI.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):7089-97.
2005: Aron Goldhirsch; JH Glick; Richard D Gelber; Alan Coates; Beat Thürlimann; Hans-Jörg Senn
Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(10):1569-83.
2005: Marco Colleoni; Sigui Li; Richard D Gelber; Karen N Price; Alan Coates; Monica Castiglione-Gertsch; Aron Goldhirsch
Relation between chemotherapy dose, oestrogen receptor expression, and body-mass index.
Lancet 2005;366(9491):1108-10.
2005: Aron Goldhirsch; Richard D Gelber; Alan Coates
What are the long-term effects of chemotherapy and hormonal therapy for early breast cancer?
Nature clinical practice. Oncology 2005;2(9):440-1.
2005: Bernard F Cole; Marco Bonetti; Alan M Zaslavsky; Richard D Gelber
A multistate Markov chain model for longitudinal, categorical quality-of-life data subject to non-ignorable missingness.
Statistics in medicine 2005;24(15):2317-34.
2005: Aron Goldhirsch; Richard D Gelber; Giuseppe Viale; Marco Colleoni; Alan Coates
Prediction of cancer outcome with microarrays.
Lancet 2005;365(9472):1685-6; author reply 1686.
2005: Marco Colleoni; Sigui Li; Richard D Gelber; Alan Coates; Monica Castiglione-Gertsch; Karen N Price; Jurij Lindtner; Carl-Magnus Rudenstam; Diana Crivellari; John Collins; Olivia Pagani; Edda Simoncini; Beat Thürlimann; Elizabeth Margaret Murray; J Forbes; D Erzen; S Holmberg; Andrea Veronesi; Aron Goldhirsch
Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer: role of endocrine responsiveness of the tumor.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(5):716-25.
2005: Steven E Lipshultz; Stuart R Lipsitz; Stephen E Sallan; Virginia M Dalton; Suzanne M Mone; Richard D Gelber; Steven D Colan
Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(12):2629-36.
2005: Silvia Dellapasqua; Marco Colleoni; Richard D Gelber; Aron Goldhirsch
Adjuvant endocrine therapy for premenopausal women with early breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(8):1736-50.
2005: Marco Colleoni; David Zahrieh; Richard D Gelber; Stig B Holmberg; Jan E Mattsson; Carl-Magnus Rudenstam; Jurij Lindtner; Darja Erzen; Raymond Snyder; John Collins; Martin F Fey; Beat Thürlimann; Diana Crivellari; Elizabeth Margaret Murray; Caesar Mendiola; Olivia Pagani; Monica Castiglione-Gertsch; Alan Coates; Karen Price; Aron Goldhirsch
Site of primary tumor has a prognostic role in operable breast cancer: the international breast cancer study group experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(7):1390-400.
2005: Eric P Winer; Clifford Hudis; Harold J Burstein; Antonio C Wolff; Kathleen I Pritchard; James N Ingle; Rowan T Chlebowski; Richard D Gelber; Stephen B Edge; Julie R Gralow; Melody A Cobleigh; Eleftherios P Mamounas; Lori J Goldstein; Timothy J Whelan; Trevor J Powles; John Bryant; Cheryl Perkins; Judy Perotti; Susan Braun; Amy S Langer; George P Browman; Mark R Somerfield
American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(3):619-29.
2004: Aron Goldhirsch; Richard D Gelber
Life with consequences of breast cancer: pregnancy during and after endocrine therapies.
Breast (Edinburgh, Scotland) 2004;13(6):443-5.
2004: Olivia Pagani; Shari Gelber; Karen Price; David Zahrieh; Richard D Gelber; Edda Simoncini; Monica Castiglione-Gertsch; Alan Coates; Aron Goldhirsch
Toremifene and tamoxifen are equally effective for early-stage breast cancer: first results of International Breast Cancer Study Group Trials 12-93 and 14-93.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(12):1749-59.
2004: Jürg Bernhard; David Zahrieh; Alan Coates; Richard D Gelber; Monica Castiglione-Gertsch; Elizabeth Margaret Murray; John Forbes; Lucien Perey; John Collins; R Snyder; Carl-Magnus Rudenstam; Diana Crivellari; Andrea Veronesi; Beat Thürlimann; Martin F Fey; Karen N Price; Aron Goldhirsch; Christoph Hürny
Quantifying trade-offs: quality of life and quality-adjusted survival in a randomised trial of chemotherapy in postmenopausal patients with lymph node-negative breast cancer.
British journal of cancer 2004;91(11):1893-901.
2004: Marco Colleoni; Giuseppe Viale; David Zahrieh; Giancarlo Pruneri; Oreste Gentilini; Paolo Veronesi; Richard D Gelber; Giuseppe Curigliano; Rosalba Torrisi; Alberto Luini; Mattia Intra; Viviana Galimberti; Giuseppe Renne; Franco Nolè; Giulia Peruzzotti; Aron Goldhirsch
Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(19):6622-8.
2004: Steven E Lipshultz; Nader Rifai; Virginia M Dalton; Donna E Levy; Lewis B Silverman; Stuart R Lipsitz; Steven D Colan; Barbara L Asselin; Ronald D Barr; Luis A Clavell; Craig A Hurwitz; Albert Moghrabi; Yvan Samson; Marshall Schorin; Richard D Gelber; Stephen E Sallan
The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia.
The New England journal of medicine 2004;351(2):145-53.
2004: Deborah P Waber; Lewis B Silverman; Lori Catania; William Mautz; Montse Rue; Richard D Gelber; Donna E Levy; Meredith A Goldwasser; Heather Adams; Annie Dufresne; Victoria Metzger; Ivonne Romero; Nancy J Tarbell; Virginia Dalton; Stephen E Sallan
Outcomes of a randomized trial of hyperfractionated cranial radiation therapy for treatment of high-risk acute lymphoblastic leukemia: therapeutic efficacy and neurotoxicity.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(13):2701-7.
2004: Marco Bonetti; Richard D Gelber
Patterns of treatment effects in subsets of patients in clinical trials.
Biostatistics (Oxford, England) 2004;5(3):465-81.
2004: Gilles Berclaz; Sigui Li; Karen N Price; Alan Coates; Monica Castiglione-Gertsch; Carl-Magnus Rudenstam; Stig B Holmberg; Jurij Lindtner; D Erien; John Collins; R Snyder; Beat Thürlimann; Martin F Fey; Caesar Mendiola; I Dudley Werner; Edda Simoncini; Diana Crivellari; Richard D Gelber; Aron Goldhirsch
Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(6):875-84.
2004: Bernard F Cole; Richard D Gelber; Shari Gelber; Pabak Mukhopadhyay
A quality-adjusted survival (Q-TWiST) model for evaluating treatments for advanced stage cancer.
Journal of biopharmaceutical statistics 2004;14(1):111-24.
2004: M Colleoni; N Rotmensz; G Martinelli; Richard D Gelber; A Coates; A Goldhirsch
Lesson learned from high-dose chemotherapy for high-risk breast cancer (What you see is what you mean).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(2):355-6.
2003: Monica Castiglione-Gertsch; Anne O'Neill; Karen N Price; Aron Goldhirsch; Alan Coates; Marco Colleoni; M Laura Nasi; Marco Bonetti; Richard D Gelber
Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial.
Journal of the National Cancer Institute 2003;95(24):1833-46.
2003: Diana Crivellari; Karen Price; Richard D Gelber; Monica Castiglione-Gertsch; Carl-Magnus Rudenstam; Jurij Lindtner; Martin F Fey; Hans-Jörg Senn; Alan Coates; John Collins; Aron Goldhirsch
Adjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of International Breast Cancer Study Group Trial IV.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(24):4517-23.
2003: H-J Senn; Beat Thürlimann; Aron Goldhirsch; William C Wood; Richard D Gelber; Alan Coates
Comments on the St. Gallen Consensus 2003 on the Primary Therapy of Early Breast Cancer.
Breast (Edinburgh, Scotland) 2003;12(6):569-82.
2003: Richard D Gelber; Marco Bonetti; Monica Castiglione-Gertsch; Alan Coates; Aron Goldhirsch
Tailoring adjuvant treatments for the individual breast cancer patient.
Breast (Edinburgh, Scotland) 2003;12(6):558-68.
2003: Marco Colleoni; David Zahrieh; Richard D Gelber; Giuseppe Viale; Alberto Luini; Paolo Veronesi; Mattia Intra; Viviana Galimberti; Giuseppe Renne; Aron Goldhirsch; D Zarieh
Preoperative systemic treatment: prediction of responsiveness.
Breast (Edinburgh, Scotland) 2003;12(6):538-42.
2003: John Goldberg; Lewis B Silverman; Donna E Levy; Virginia Dalton; Richard D Gelber; Leslie E Lehmann; Harvey Jay Cohen; Stephen E Sallan; Barbara L Asselin
Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(19):3616-22.
2003: Aron Goldhirsch; William C Wood; Richard D Gelber; Alan Coates; Beat Thürlimann; Hans-Jörg Senn
Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(17):3357-65.
2003: Virginia Dalton; Montse Rue; Lewis B Silverman; Richard D Gelber; Barbara L Asselin; Ronald D Barr; Luis A Clavell; Craig A Hurwitz; Albert Moghrabi; Yvan Samson; Marshall Schorin; Nancy J Tarbell; Stephen E Sallan; Laurie E Cohen
Height and weight in children treated for acute lymphoblastic leukemia: relationship to CNS treatment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(15):2953-60.
2003: Aron Goldhirsch; Marco Colleoni; G Domenighetti; Richard D Gelber
Systemic treatments for women with breast cancer: outcome with relation to screening for the disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(8):1212-4.
2003: Arne Wallgren; Marco Bonetti; Richard D Gelber; Aron Goldhirsch; Monica Castiglione-Gertsch; Stig B Holmberg; Jurij Lindtner; Beat Thürlimann; M Fey; I D Werner; John Forbes; Karen Price; Alan Coates; John Collins
Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(7):1205-13.
2003: Vito J Spataro; Heather Litman; Giuseppe Viale; Fausto Antonio Maffini; Michele Masullo; Rastko Golouh; Francisco J Martinez-Tello; Piergioranni Grigolato; Keith B Shilkin; Barry A Gusterson; Monica Castiglione-Gertsch; Karen Price; Jurij Lindtner; Hernán Cortés-Funes; Edda Simoncini; Michael J Byrne; John Collins; Richard D Gelber; Alan Coates; Aron Goldhirsch
Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status: results from International Breast Cancer Study Group Trial V.
Cancer 2003;97(7):1591-600.
2003: Helen Trihia; Susan Murray; Karen Price; Richard D Gelber; Rastko Golouh; Aron Goldhirsch; Alan Coates; John Collins; Monica Castiglione-Gertsch; Barry A Gusterson
Ki-67 expression in breast carcinoma: its association with grading systems, clinical parameters, and other prognostic factors--a surrogate marker?
Cancer 2003;97(5):1321-31.
2002: Steven E Lipshultz; Stuart R Lipsitz; Stephen E Sallan; Valeriano C Simbre; Seema L Shaikh; Suzanne M Mone; Richard D Gelber; Steven D Colan
Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(23):4517-22.
2002: Alan Coates; Aron Goldhirsch; Richard D Gelber
Overhauling the breast cancer overview: are subsets subversive?
The lancet oncology 2002;3(9):525-6.
2002: Marco Colleoni; H J Litman; Monica Castiglione-Gertsch; Willi Sauerbrei; Richard D Gelber; Marco Bonetti; Alan Coates; M Schumacher; G Bastert; Carl-Magnus Rudenstam; Claudia Schmoor; Jurij Lindtner; John Collins; Beat Thürlimann; Stig B Holmberg; Diana Crivellari; C Beyerle; R L A Neumann; Aron Goldhirsch
Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF.
British journal of cancer 2002;86(11):1705-14.
2002: Craig C Earle; Peter J Neumann; Richard D Gelber; Milton C Weinstein; Jane C Weeks
Impact of referral patterns on the use of chemotherapy for lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(7):1786-92.
2002: Steven E Lipshultz; Amy L Giantris; Stuart R Lipsitz; Virginia Kimball Dalton; Barbara L Asselin; Ronald D Barr; Luis A Clavell; Craig A Hurwitz; Albert Moghrabi; Yvan Samson; Marshall Schorin; Richard D Gelber; Stephen E Sallan; Steven D Colan
Doxorubicin administration by continuous infusion is not cardioprotective: the Dana-Farber 91-01 Acute Lymphoblastic Leukemia protocol.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(6):1677-82.
2002: Aron Goldhirsch; Marco Colleoni; Richard D Gelber
Endocrine therapy of breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13 Suppl 4():61-8.
2002: Jean Marie LeClerc; Amy L Billett; Richard D Gelber; Virginia Dalton; Nancy J Tarbell; Jeffrey Lipton; Ronald Barr; Luis A Clavell; Barbara L Asselin; Craig A Hurwitz; Marshall Schorin; Steven E Lipshultz; Lieven Declerck; Lewis B Silverman; Harvey Jay Cohen; Stephen E Sallan
Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber ALL Consortium Protocol 87-01.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(1):237-46.
2001: Marco Colleoni; Shari Gelber; Alan Coates; Monica Castiglione-Gertsch; Richard D Gelber; Karen Price; Carl-Magnus Rudenstam; Jurij Lindtner; John Collins; Beat Thürlimann; Stig B Holmberg; H Cortes-Funes; Edda Simoncini; Elizabeth Margaret Murray; M Fey; Aron Goldhirsch
Influence of endocrine-related factors on response to perioperative chemotherapy for patients with node-negative breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(21):4141-9.
2001: Aron Goldhirsch; JH Glick; Richard D Gelber; Alan Coates; Hans-Jörg Senn
Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(18):3817-27.
2001: Bernard F Cole; Richard D Gelber; Shari Gelber; Alan Coates; Aron Goldhirsch
Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysis.
Lancet 2001;358(9278):277-86.
2001: Deborah P Waber; B L Shapiro; Sarah C Carpentieri; Richard D Gelber; G Zou; A Dufresne; Ivonne Romero; Nancy J Tarbell; Lewis B Silverman; Stephen E Sallan
Excellent therapeutic efficacy and minimal late neurotoxicity in children treated with 18 grays of cranial radiation therapy for high-risk acute lymphoblastic leukemia: a 7-year follow-up study of the Dana-Farber Cancer Institute Consortium Protocol 87-01.
Cancer 2001;92(1):15-22.
2001: A J Strauss; J T Su; Virginia M Dalton; Richard D Gelber; Stephen E Sallan; Lewis B Silverman
Bony morbidity in children treated for acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(12):3066-72.
2001: Shari Gelber; Alan Coates; Aron Goldhirsch; Monica Castiglione-Gertsch; G Marini; Jurij Lindtner; D Z Edelmann; A Gudgeon; V Harvey; Richard D Gelber
Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(6):1671-5.
2001: Lewis B Silverman; Richard D Gelber; Virginia Dalton; Barbara L Asselin; Ronald D Barr; Luis A Clavell; Craig A Hurwitz; Albert Moghrabi; Yvan Samson; Marshall Schorin; S Arkin; Lieven Declerck; Harvey Jay Cohen; Stephen E Sallan
Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01.
Blood 2001;97(5):1211-8.
2001: Craig C Earle; J S Tsai; Richard D Gelber; Milton C Weinstein; Peter J Neumann; Jane C Weeks
Effectiveness of chemotherapy for advanced lung cancer in the elderly: instrumental variable and propensity analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(4):1064-70.
2001: C L Schwartz; E B Thompson; Richard D Gelber; ML Young; DG Chilton; Harvey Jay Cohen; Stephen E Sallan
Improved response with higher corticosteroid dose in children with acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(4):1040-6.
2001: Aron Goldhirsch; Richard D Gelber; G Yothers; R J Gray; S Green; J Bryant; Shari Gelber; Monica Castiglione-Gertsch; Alan Coates
Adjuvant therapy for very young women with breast cancer: need for tailored treatments.
Journal of the National Cancer Institute. Monographs 2001;(30):44-51.
2001: Paul R B Kitchen; T H Smith; Michael A Henderson; Aron Goldhirsch; Monica Castiglione-Gertsch; Alan Coates; B Gusterson; R W Brown; Richard D Gelber; John P Collins
Tubular carcinoma of the breast: prognosis and response to adjuvant systemic therapy.
ANZ journal of surgery 2001;71(1):27-31.
2000: Lewis B Silverman; Lieven Declerck; Richard D Gelber; Virginia Dalton; Barbara L Asselin; Ronald D Barr; Luis A Clavell; Craig A Hurwitz; Albert Moghrabi; Yvan Samson; Marshall Schorin; Jeffrey Lipton; Harvey Jay Cohen; Stephen E Sallan
Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995).
Leukemia 2000;14(12):2247-56.
2000: Marco Colleoni; Anne O'Neill; Aron Goldhirsch; Richard D Gelber; Marco Bonetti; Beat Thürlimann; Karen N Price; Monica Castiglione-Gertsch; Alan Coates; Jurij Lindtner; John Collins; Hans-Jörg Senn; Franco Cavalli; J Forbes; A Gudgeon; Edda Simoncini; H Cortes-Funes; Andrea Veronesi; M Fey; Carl-Magnus Rudenstam
Identifying breast cancer patients at high risk for bone metastases.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(23):3925-35.
2000: Alan Coates; Christoph Hürny; HF Peterson; Jürg Bernhard; Monica Castiglione-Gertsch; Richard D Gelber; Aron Goldhirsch
Quality-of-life scores predict outcome in metastatic but not early breast cancer. International Breast Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(22):3768-74.
2000: Marco Bonetti; Richard D Gelber
A graphical method to assess treatment-covariate interactions using the Cox model on subsets of the data.
Statistics in medicine 2000;19(19):2595-609.
2000: A Goldhirsch; P Francis; M Castiglione-Gertsch; Richard D Gelber; Alan Coates
Taxanes as adjuvant for breast cancer.
Lancet 2000;356(9228):507-8.
2000: Stefan Aebi; Shari Gelber; Monica Castiglione-Gertsch; Richard D Gelber; John Collins; Beat Thürlimann; Carl-Magnus Rudenstam; Jurij Lindtner; Diana Crivellari; H Cortes-Funes; Edda Simoncini; I Dudley Werner; Alan Coates; Aron Goldhirsch
Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?
Lancet 2000;355(9218):1869-74.
2000: Craig C Earle; L N Venditti; P J Neumann; Richard D Gelber; Milton C Weinstein; A L Potosky; Jane C Weeks
Who gets chemotherapy for metastatic lung cancer?
Chest 2000;117(5):1239-46.
2000: Craig A Hurwitz; Lewis B Silverman; Marshall Schorin; Luis A Clavell; Virginia Dalton; K M Glick; Richard D Gelber; Stephen E Sallan
Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia.
Cancer 2000;88(8):1964-9.
2000: Diana Crivellari; Marco Bonetti; Monica Castiglione-Gertsch; Richard D Gelber; Carl-Magnus Rudenstam; Beat Thürlimann; Karen N Price; Alan Coates; Christoph Hürny; Jürg Bernhard; Jurij Lindtner; John Collins; Hans-Jörg Senn; Franco Cavalli; J Forbes; A Gudgeon; Edda Simoncini; H Cortes-Funes; Andrea Veronesi; M Fey; Aron Goldhirsch
Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(7):1412-22.
2000: M Castiglione-Gertsch; Richard D Gelber; A O'Neill; Alan Coates; A Goldhirsch
Systemic adjuvant treatment for premenopausal node-negative breast cancer. The International Breast Cancer Study Group.
European journal of cancer (Oxford, England : 1990) 2000;36(4):549-50.
2000: Marco Colleoni; Marco Bonetti; Alan Coates; Monica Castiglione-Gertsch; Richard D Gelber; Karen Price; Carl-Magnus Rudenstam; Jurij Lindtner; John Collins; Beat Thürlimann; S Holmberg; Andrea Veronesi; G Marini; Aron Goldhirsch
Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(3):584-90.
1999: Richard J Cote; HF Peterson; Benjaporn Chaiwun; Richard D Gelber; Aron Goldhirsch; Monica Castiglione-Gertsch; Barry A Gusterson; A M Neville
Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group.
Lancet 1999;354(9182):896-900.
1999: M Colleoni; Karen N Price; Monica Castiglione-Gertsch; Richard D Gelber; Alan Coates; A Goldhirsch
Mortality during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil. International Breast Cancer Study Group.
Lancet 1999;354(9173):130-1.
1999: Susan K Parsons; Shari Gelber; Bernard F Cole; Yaddanapudi Ravindranath; A Ogden; A M Yeager; M Chang; J Shuster; Howard J Weinstein; Richard D Gelber
Quality-adjusted survival after treatment for acute myeloid leukemia in childhood: A Q-TWiST analysis of the Pediatric Oncology Group Study 8821.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(7):2144-52.
1999: Lewis B Silverman; Richard D Gelber; ML Young; Virginia Dalton; Ronald D Barr; Stephen E Sallan
Induction failure in acute lymphoblastic leukemia of childhood.
Cancer 1999;85(6):1395-404.
1999: Barbara L Asselin; S Kreissman; D J Coppola; S D Bernal; P R Leavitt; Richard D Gelber; Stephen E Sallan; Harvey Jay Cohen
Prognostic significance of early response to a single dose of asparaginase in childhood acute lymphoblastic leukemia.
Journal of pediatric hematology/oncology 1999;21(1):6-12.
1998: Alan Coates; Richard D Gelber; A Goldhirsch
Subsets within the chemotherapy overview. International Breast Cancer Study Group.
Lancet 1998;352(9142):1783-4.
1998: Aron Goldhirsch; JH Glick; Richard D Gelber; Hans-Jörg Senn
Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer.
Journal of the National Cancer Institute 1998;90(21):1601-8.
1998: Sarah Elizabeth Pinder; S Murray; Ian O Ellis; Helen Trihia; C W Elston; Richard D Gelber; Aron Goldhirsch; Jurij Lindtner; Hernán Cortés-Funes; Edda Simoncini; Michael J Byrne; Rastko Golouh; Carl-Magnus Rudenstam; Monica Castiglione-Gertsch; Barry A Gusterson
The importance of the histologic grade of invasive breast carcinoma and response to chemotherapy.
Cancer 1998;83(8):1529-39.
1998: Marco Colleoni; Karen Price; Monica Castiglione-Gertsch; Aron Goldhirsch; Alan Coates; Jurij Lindtner; John Collins; Richard D Gelber; Beat Thürlimann; Carl-Magnus Rudenstam
Dose-response effect of adjuvant cyclophosphamide, methotrexate, 5-fluorouracil (CMF) in node-positive breast cancer. International Breast Cancer Study Group.
European journal of cancer (Oxford, England : 1990) 1998;34(11):1693-700.
1998: Aron Goldhirsch; Alan Coates; Monica Castiglione-Gertsch; Richard D Gelber
New treatments for breast cancer: breakthroughs for patient care or just steps in the right direction?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(9):973-6.
1998: Jürg Bernhard; Christoph Hürny; Alan Coates; HF Peterson; Monica Castiglione-Gertsch; Richard D Gelber; E Galligioni; G Marini; Beat Thürlimann; John Forbes; Aron Goldhirsch; Hans-Jörg Senn; Carl-Magnus Rudenstam
Factors affecting baseline quality of life in two international adjuvant breast cancer trials. International Breast Cancer Study Group (IBCSG).
British journal of cancer 1998;78(5):686-93.
1998: V M Kimball Dalton; Richard D Gelber; Frederick P Li; M J Donnelly; Nancy J Tarbell; Stephen E Sallan
Second malignancies in patients treated for childhood acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(8):2848-53.
1998: Bernard F Cole; Philippe Solal-Céligny; Richard D Gelber; Eric Lepage; C Gisselbrecht; F Reyes; Catherine Sebban; D Sugano; C Tendler; A Goldhirsch
Quality-of-life-adjusted survival analysis of interferon alfa-2b treatment for advanced follicular lymphoma: an aid to clinical decision making.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(7):2339-44.
1998: Aron Goldhirsch; Marco Colleoni; Alan Coates; Monica Castiglione-Gertsch; Richard D Gelber
Adding adjuvant CMF chemotherapy to either radiotherapy or tamoxifen: are all CMFs alike? The International Breast Cancer Study Group (IBCSG).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(5):489-93.
1998: Olivia Pagani; Anne O'Neill; Monica Castiglione; Richard D Gelber; Aron Goldhirsch; Carl-Magnus Rudenstam; Jurij Lindtner; John Collins; Diana Crivellari; Alan Coates; Franco Cavalli; Beat Thürlimann; Edda Simoncini; M Fey; Karen Price; Hans-Jörg Senn
Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VI.
European journal of cancer (Oxford, England : 1990) 1998;34(5):632-40.
1998: Aron Goldhirsch; Alan Coates; Marco Colleoni; Monica Castiglione-Gertsch; Richard D Gelber
Adjuvant chemoendocrine therapy in postmenopausal breast cancer: cyclophosphamide, methotrexate, and fluorouracil dose and schedule may make a difference. International Breast Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(4):1358-62.
1998: Jürg Bernhard; HF Peterson; Alan Coates; H Gusset; M Isley; R Hinkle; Richard D Gelber; Monica Castiglione-Gertsch; Christoph Hürny
Quality of life assessment in International Breast Cancer Study Group (IBCSG) trials: practical issues and factors associated with missing data.
Statistics in medicine 1998;17(5-7):587-601.
1998: A Goldhirsch; Alan Coates; M Colleoni; Richard D Gelber
Radiotherapy and chemotherapy in high-risk breast cancer.
The New England journal of medicine 1998;338(5):330-1; author reply 331-2.
1998: Aron Goldhirsch; JH Glick; Richard D Gelber; Hans-Jörg Senn
International Consensus Panel on the treatment of primary breast cancer. V: Update 1998.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1998;152():481-97.
1998: Richard D Gelber; Marco Bonetti; Bernard F Cole; Shari Gelber; Aron Goldhirsch
Quality of life assessment in the adjuvant setting: is it relevant? International Breast Cancer Study Group.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1998;152():373-89.
1997: Lewis B Silverman; Thomas Williams McLean; Richard D Gelber; M J Donnelly; D G Gilliland; Nancy J Tarbell; Stephen E Sallan
Intensified therapy for infants with acute lymphoblastic leukemia: results from the Dana-Farber Cancer Institute Consortium.
Cancer 1997;80(12):2285-95.
1997: Monica Castiglione-Gertsch; M Tattersall; A Hacking; Aron Goldhirsch; A Gudgeon; Richard D Gelber; Jurij Lindtner; Alan Coates; John Collins; M Isley; Hans-Jörg Senn; Carl-Magnus Rudenstam
Retreating recurrent breast cancer with the same CMF-containing regimen used as adjuvant therapy. The International Breast Cancer Study Group.
European journal of cancer (Oxford, England : 1990) 1997;33(14):2321-5.
1997: Jürg Bernhard; Christoph Hürny; Alan Coates; HF Peterson; Monica Castiglione-Gertsch; Richard D Gelber; Aron Goldhirsch; Hans-Jörg Senn; Carl-Magnus Rudenstam
Quality of life assessment in patients receiving adjuvant therapy for breast cancer: the IBCSG approach. The International Breast Cancer Study Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(9):825-35.
1997: Aron Goldhirsch; Richard D Gelber; Monica Castiglione; Anne O'Neill; Beat Thürlimann; Carl-Magnus Rudenstam; Jurij Lindtner; John Collins; J Forbes; Diana Crivellari; Alan Coates; Franco Cavalli; Edda Simoncini; Martin F Fey; Olivia Pagani; Karen Price; Hans-Jörg Senn
Menstrual cycle and timing of breast surgery in premenopausal node-positive breast cancer: results of the International Breast Cancer Study Group (IBCSG) Trial VI.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(8):751-6.
1997: Bernhard C Pestalozzi; HF Peterson; Richard D Gelber; Aron Goldhirsch; Barry A Gusterson; Helen Trihia; Jurij Lindtner; Hernán Cortés-Funes; E Simmoncini; Michael J Byrne; Rastko Golouh; Carl-Magnus Rudenstam; Monica Castiglione-Gertsch; Carmen J Allegra; Patrick G Johnston
Prognostic importance of thymidylate synthase expression in early breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(5):1923-31.
1996: Bernard F Cole; Richard D Gelber; J M Kirkwood; A Goldhirsch; E Barylak; E Borden
Quality-of-life-adjusted survival analysis of interferon alfa-2b adjuvant treatment of high-risk resected cutaneous melanoma: an Eastern Cooperative Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(10):2666-73.
1996: Richard D Gelber; Aron Goldhirsch; Bernard F Cole; H S Wieand; G Schroeder; J E Krook
A quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of adjuvant radiation therapy and chemotherapy for resectable rectal cancer.
Journal of the National Cancer Institute 1996;88(15):1039-45.
1996: Aron Goldhirsch; Richard D Gelber
Endocrine therapies of breast cancer.
Seminars in oncology 1996;23(4):494-505.
1996: Arne Wallgren; J Bernier; Richard D Gelber; A Goldhirsch; M Roncadin; D Joseph; M Castiglione-Gertsch
Timing of radiotherapy and chemotherapy following breast-conserving surgery for patients with node-positive breast cancer. International Breast Cancer Study Group.
International journal of radiation oncology, biology, physics 1996;35(4):649-59.
1996: Christoph Hürny; Jürg Bernhard; Alan Coates; Monica Castiglione-Gertsch; HF Peterson; Richard D Gelber; J F Forbes; Carl-Magnus Rudenstam; Edda Simoncini; D Crivellari; Aron Goldhirsch; Hans-Jörg Senn
Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer. International Breast Cancer Study Group.
Lancet 1996;347(9011):1279-84.
1996: Richard D Gelber; B F Cole; A Goldhirsch; C Rose; B Fisher; C Kent Osborne; F Boccardo; R Gray; N H Gordon; N O Bengtsson; P Sevelda
Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: meta-analysis of quality-adjusted survival.
Lancet 1996;347(9008):1066-71.
1996: Richard D Gelber
Gemcitabine for pancreatic cancer: how hard to look for clinical benefit? An American perspective.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(4):335-7.
1996: G Marini; S Murray; Aron Goldhirsch; Richard D Gelber; Monica Castiglione-Gertsch; K N Price; M H Tattersall; Carl-Magnus Rudenstam; John Collins; Jurij Lindtner; Franco Cavalli; Hernán Cortés-Funes; A Gudgeon; J F Forbes; E Galligioni; Alan Coates; Hans-Jörg Senn
The effect of adjuvant prednisone combined with CMF on patterns of relapse and occurrence of second malignancies in patients with breast cancer. International (Ludwig) Breast Cancer Study Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(3):245-50.
1996: Christoph Hürny; Jürg Bernhard; Alan Coates; HF Peterson; Monica Castiglione-Gertsch; Richard D Gelber; Carl-Magnus Rudenstam; John Collins; Jurij Lindtner; Aron Goldhirsch; Hans-Jörg Senn
Responsiveness of a single-item indicator versus a multi-item scale: assessment of emotional well-being in an international adjuvant breast cancer trial.
Medical care 1996;34(3):234-48.
1996: Aron Goldhirsch; W C Wood; H J Senn; J H Glick; Richard D Gelber
IX. International consensus conference on primary treatment of breast cancer.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1996;140():325-35.
1996: Monica Castiglione-Gertsch; Richard D Gelber; Aron Goldhirsch
Adjuvant systemic therapy: the issues of timing and sequence.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1996;140():201-13.
1995: Aron Goldhirsch; W C Wood; H J Senn; J H Glick; Richard D Gelber
Meeting highlights: international consensus panel on the treatment of primary breast cancer.
Journal of the National Cancer Institute 1995;87(19):1441-5.
1995: Diana Crivellari; K N Price; M Hagen; Aron Goldhirsch; Richard D Gelber; Monica Castiglione; Alan Coates; Carl-Magnus Rudenstam; John Collins; Jurij Lindtner
Routine tests during follow-up of patients after primary treatment for operable breast cancer. International (Ludwig) Breast Cancer Study Group (IBCSG)
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(8):769-76.
1995: A Goldhirsch; W C Wood; H J Senn; J H Glick; Richard D Gelber
Fifth International Conference on Adjuvant Therapy of Breast Cancer, St Gallen, March 1995. International Consensus Panel on the Treatment of Primary Breast Cancer.
European journal of cancer (Oxford, England : 1990) 1995;31A(11):1754-9.
1995: Bernard F Cole; Richard D Gelber; A Goldhirsch
A quality-adjusted survival meta-analysis of adjuvant chemotherapy for premenopausal breast cancer. International Breast Cancer Study Group.
Statistics in medicine 1995;14(16):1771-84.
1995: C E Schwartz; B F Cole; Richard D Gelber
Measuring patient-centered outcomes in neurologic disease. Extending the Q-TWiST method.
Archives of neurology 1995;52(8):754-62.
1995: Richard D Gelber; Bernard F Cole; Aron Goldhirsch; G Bonadonna; A Howell; C S McArdle; H T Mouridsen; R D Rubens; K Welvaart
Adjuvant chemotherapy for premenopausal breast cancer: a meta-analysis using quality-adjusted survival.
The cancer journal from Scientific American 1995;1(2):114-21.
1995: Steven E Lipshultz; S R Lipsitz; S M Mone; A M Goorin; Stephen E Sallan; S P Sanders; E John Orav; Richard D Gelber; Steven D Colan
Female sex and drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer.
The New England journal of medicine 1995;332(26):1738-43.
1995: C E Schwartz; B F Cole; B G Vickrey; Richard D Gelber
The Q-TWiST approach to assessing health-related quality of life in epilepsy.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 1995;4(2):135-41.
1995: C Hürny; Jürg Bernhard; A Coates; HF Peterson; Richard D Gelber
The quality of quality-of-life measurements.
JAMA : the journal of the American Medical Association 1995;273(11):843; author reply 844-5.
1995: Aron Goldhirsch; Richard D Gelber; Monica Castiglione; K N Price; Carl-Magnus Rudenstam; Jurij Lindtner; John Collins; Hans-Jörg Senn; Franco Cavalli; E Galligioni
The best available adjuvant treatments are within the framework of clinical trials. The International Breast Cancer Study Group.
Israel journal of medical sciences 1995;31(2-3):144-54.
1995: Richard D Gelber; Shari Gelber
Quality-of-life assessment in clinical trials.
Cancer treatment and research 1995;75():225-46.
1994: Monica Castiglione-Gertsch; C Johnsen; Aron Goldhirsch; Richard D Gelber; Carl-Magnus Rudenstam; John Collins; Jurij Lindtner; A Hacking; H Cortes-Funes; J Forbes
The International (Ludwig) Breast Cancer Study Group Trials I-IV: 15 years follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(8):717-24.
1994: Bernard F Cole; Richard D Gelber; K M Anderson
Parametric approaches to quality-adjusted survival analysis. International Breast Cancer Study Group.
Biometrics 1994;50(3):621-31.
1994: Aron Goldhirsch; Richard D Gelber; Monica Castiglione; K N Price; Carl-Magnus Rudenstam; Jurij Lindtner; John Collins; Hans-Jörg Senn; K W Brunner; E Galligioni
Present and future projects of the International Breast Cancer Study Group.
Cancer 1994;74(3 Suppl):1139-49.
1994: A Goldhirsch; Richard D Gelber
Understanding adjuvant chemotherapy for breast cancer.
The New England journal of medicine 1994;330(18):1308-9.
1994: Richard D Gelber; A Goldhirsch
Radiotherapy to the conserved breast: is it avoidable if the cancer is small?
Journal of the National Cancer Institute 1994;86(9):652-4.
1994: A Goldhirsch; Richard D Gelber; M Castiglione
Testing tumor dormancy in breast cancer.
Journal of the National Cancer Institute 1994;86(7):558.
1994: M A Schorin; S Blattner; Richard D Gelber; Nancy J Tarbell; M Donnelly; V Dalton; H J Cohen; Stephen E Sallan
Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber Cancer Institute/Children's Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85-01.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(4):740-7.
1994: William R Lenderking; Richard D Gelber; Deborah Cotton; Bernard F Cole; Aron Goldhirsch; P A Volberding; Marcia A Testa
Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. The AIDS Clinical Trials Group.
The New England journal of medicine 1994;330(11):738-43.
1994: Aron Goldhirsch; Richard D Gelber; K N Price; Monica Castiglione; Alan Coates; Carl-Magnus Rudenstam; John Collins; Jurij Lindtner; A Hacking; G Marini
Effect of systemic adjuvant treatment on first sites of breast cancer relapse.
Lancet 1994;343(8894):377-81.
1994: Christoph Hürny; Jürg Bernhard; Alan Coates; Monica Castiglione; HF Peterson; Richard D Gelber; Carl-Magnus Rudenstam; Aron Goldhirsch; Hans-Jörg Senn
Timing of baseline quality of life assessment in an international adjuvant breast cancer trial: its effect on patient self-estimation. The International Breast Cancer Study Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(1):65-74.
1993: Richard D Gelber; Aron Goldhirsch; Bernard F Cole
Parametric extrapolation of survival estimates with applications to quality of life evaluation of treatments. International Breast Cancer Study Group.
Controlled clinical trials 1993;14(6):485-99.
1993: Richard D Gelber; A Goldhirsch; M Castiglione; C M Rudenstram; J Collins; H J Senn
Premenopausal oopherectomy versus CMF chemotherapy in stage II breast carcinoma. The International Breast Cancer Study Group (IBCSG)
Lancet 1993;342(8866):305.
1993: Richard D Gelber; Stephen E Sallan; H J Cohen; M Donnelly; V Dalton; F Tobia; L A Clavell; Nancy J Tarbell
Central nervous system treatment in childhood acute lymphoblastic leukemia. Long-term follow-up of patients diagnosed between 1973 and 1985.
Cancer 1993;72(1):261-70.
1993: N J Tarbell; Richard D Gelber; H J Weinstein; Peter M Mauch
Sex differences in risk of second malignant tumours after Hodgkin's disease in childhood.
Lancet 1993;341(8858):1428-32.
1993: Bernard F Cole; Richard D Gelber; A Goldhirsch
Cox regression models for quality adjusted survival analysis.
Statistics in medicine 1993;12(10):975-87.
1993: C Zerbini; Richard D Gelber; D Weinberg; Stephen E Sallan; P Barnes; William J Kupsky; rmichael Scott; Nancy J Tarbell
Prognostic factors in medulloblastoma, including DNA ploidy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(4):616-22.
1993: Amy L Billett; E Kornmehl; Nancy J Tarbell; Howard J Weinstein; Richard D Gelber; Jerome Ritz; Stephen E Sallan
Autologous bone marrow transplantation after a long first remission for children with recurrent acute lymphoblastic leukemia.
Blood 1993;81(6):1651-7.
1993: Richard D Gelber; Aron Goldhirsch; Alan Coates
Adjuvant therapy for breast cancer: understanding the overview. International Breast Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(3):580-5.
1993: J H Glick; Richard D Gelber; A Goldhirsch; H J Senn
Adjuvant therapy of primary breast cancer: closing summary.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;127():289-300.
1993: Richard D Gelber; B F Cole; A Goldhirsch
How to compare quality of life of breast cancer patients in clinical trials. International Breast Cancer Study Group.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;127():221-33.
1993: Richard D Gelber; A Goldhirsch
From the overview to the patient: how to interpret meta-analysis data.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;127():167-76.
1993: Richard D Gelber; Aron Goldhirsch; Bernard F Cole
Evaluation of effectiveness: Q-TWiST. The International Breast Cancer Study Group.
Cancer treatment reviews 1993;19 Suppl A():73-84.
1992: J H Glick; Richard D Gelber; A Goldhirsch; H J Senn
Adjuvant therapy of primary breast cancer. 4th International Conference on Adjuvant Therapy of Primary Breast Cancer St. Gallen, Switzerland.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(10):801-7.
1992: V Spataro; Karen Price; Aron Goldhirsch; Franco Cavalli; Edda Simoncini; Monica Castiglione; Carl-Magnus Rudenstam; John Collins; Jurij Lindtner; Richard D Gelber
Sequential estrogen receptor determinations from primary breast cancer and at relapse: prognostic and therapeutic relevance. The International Breast Cancer Study Group (formerly Ludwig Group).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(9):733-40.
1992: Richard D Gelber; Alan Coates; A Goldhirsch
Meta-analysis: the fashion of summing-up evidence. Part II: Interpretations and uses.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(9):683-91.
1992: S G Kreissman; Richard D Gelber; H J Cohen; L A Clavell; P Leavitt; Stephen E Sallan
Incidence of secondary acute myelogenous leukemia after treatment of childhood acute lymphoblastic leukemia.
Cancer 1992;70(8):2208-13.
1992: J H Glick; Richard D Gelber; A Goldhirsch; H J Senn
Meeting highlights: adjuvant therapy for primary breast cancer.
Journal of the National Cancer Institute 1992;84(19):1479-85.
1992: Amy L Billett; A Carls; Richard D Gelber; Stephen E Sallan
Allergic reactions to Erwinia asparaginase in children with acute lymphoblastic leukemia who had previous allergic reactions to Escherichia coli asparaginase.
Cancer 1992;70(1):201-6.
1992: barry gusterson; Richard D Gelber; Aron Goldhirsch; K N Price; J Säve-Söderborgh; R Anbazhagan; J Styles; Carl-Magnus Rudenstam; Rastko Golouh; R Reed
Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(7):1049-56.
1992: Richard D Gelber; William R Lenderking; Deborah Cotton; Bernard F Cole; Margaret A Fischl; Aron Goldhirsch; Marcia A Testa
Quality-of-life evaluation in a clinical trial of zidovudine therapy in patients with mildly symptomatic HIV infection. The AIDS Clinical Trials Group.
Annals of internal medicine 1992;116(12 Pt 1):961-6.
1992: D P Waber; Nancy J Tarbell; C M Kahn; Richard D Gelber; Stephen E Sallan
The relationship of sex and treatment modality to neuropsychologic outcome in childhood acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(5):810-7.
1992: A M Neville; R Bettelheim; Richard D Gelber; J Säve-Söderbergh; B W Davis; R Reed; J Torhorst; Rastko Golouh; HF Peterson; K N Price
Factors predicting treatment responsiveness and prognosis in node-negative breast cancer. The International (Ludwig) Breast Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(5):696-705.
1992: Richard D Gelber; Alan Coates; A Goldhirsch
Adjuvant treatment for breast cancer: the overview.
BMJ (Clinical research ed.) 1992;304(6831):859-60.
1992: R Drigan; A Spirito; Richard D Gelber
Behavioral effects of corticosteroids in children with acute lymphoblastic leukemia.
Medical and pediatric oncology 1992;20(1):13-21.
1992: A Goldhirsch; M Castiglione; Richard D Gelber
A single perioperative adjuvant chemotherapy course for node-negative breast cancer: five-year results of trial V. International Breast Cancer Study Group (formerly Ludwig Group).
Journal of the National Cancer Institute. Monographs 1992;(11):89-96.
1992: Christoph Hürny; Jürg Bernhard; Richard D Gelber; Alan Coates; Monica Castiglione; M Isley; D Dreher; H Peterson; Aron Goldhirsch; Hans-Jörg Senn
Quality of life measures for patients receiving adjuvant therapy for breast cancer: an international trial. The International Breast Cancer Study Group.
European journal of cancer (Oxford, England : 1990) 1992;28(1):118-24.
1992: Richard D Gelber; A Goldhirsch
Reporting and interpreting adjuvant therapy clinical trials. International Breast Cancer Study Group (formerly Ludwig Group).
Journal of the National Cancer Institute. Monographs 1992;(11):59-69.
1992: Richard D Gelber; A Goldhirsch; C Hürny; Jürg Bernhard; R J Simes
Quality of life in clinical trials of adjuvant therapies. International Breast Cancer Study Group (formerly Ludwig Group).
Journal of the National Cancer Institute. Monographs 1992;(11):127-35.
1992: Holcombe E Grier; Richard D Gelber; Michael P Link; B P Camitta; L A Clavell; H J Weistein
Intensive sequential chemotherapy for children with acute myelogenous leukemia: VAPA, 80-035, and HI-C-Daze.
Leukemia 1992;6 Suppl 2():48-51.
1992: Richard D Gelber; A Goldhirsch
Models for weighing benefits and toxicities.
Cancer treatment and research 1992;60():189-206.
1991: C M Niemeyer; Richard D Gelber; Nancy J Tarbell; M Donnelly; L A Clavell; S R Blattner; K Donahue; H J Cohen; Stephen E Sallan
Low-dose versus high-dose methotrexate during remission induction in childhood acute lymphoblastic leukemia (Protocol 81-01 update).
Blood 1991;78(10):2514-9.
1991: C M Niemeyer; A Reiter; H Riehm; M Donnelly; Richard D Gelber; Stephen E Sallan
Comparative results of two intensive treatment programs for childhood acute lymphoblastic leukemia: The Berlin-Frankfurt-Münster and Dana-Farber Cancer Institute protocols.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2(10):745-9.
1991: C W Taylor; R Anbazhagan; H Jayatilake; A Adams; Barry A Gusterson; K Price; Richard D Gelber; A Goldhirsch
Helix pomatia in breast cancer.
Lancet 1991;338(8766):580-1.
1991: Richard D Gelber; A Goldhirsch
Meta-analysis: the fashion of summing-up evidence. Part I. Rationale and conduct.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2(7):461-8.
1991: A M Neville; K N Price; Richard D Gelber; A Goldhirsch
Axillary node micrometastases and breast cancer.
Lancet 1991;337(8749):1110.
1991: Richard D Gelber; Aron Goldhirsch; Franco Cavalli
Quality-of-life-adjusted evaluation of adjuvant therapies for operable breast cancer. The International Breast Cancer Study Group.
Annals of internal medicine 1991;114(8):621-8.
1991: Steven E Lipshultz; Steven D Colan; Richard D Gelber; Antonio R Perez-Atayde; Stephen E Sallan; S P Sanders
Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood.
The New England journal of medicine 1991;324(12):808-15.
1991: A Goldhirsch; Richard D Gelber; M Castiglione
Adjuvant therapy of breast cancer. International Breast Cancer Study Group.
European journal of cancer (Oxford, England : 1990) 1991;27(3):389-99.
1991: R Anbazhagan; Richard D Gelber; R Bettelheim; A Goldhirsch; barry gusterson
Association of c-erbB-2 expression and S-phase fraction in the prognosis of node positive breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2(1):47-53.
1990: A L Sonis; Nancy J Tarbell; R W Valachovic; Richard D Gelber; M Schwenn; Stephen E Sallan
Dentofacial development in long-term survivors of acute lymphoblastic leukemia. A comparison of three treatment modalities.
Cancer 1990;66(12):2645-52.
1990: D P Byar; David Schoenfeld; S B Green; D A Amato; R Davis; Victor De Gruttola; D M Finkelstein; C Gatsonis; Richard D Gelber; Stephen W Lagakos
Design considerations for AIDS trials.
The New England journal of medicine 1990;323(19):1343-8.
1990: Gregory D Longmore; Eva C Guinan; Howard J Weinstein; Richard D Gelber; J M Rappeport; Joseph H Antin
Bone marrow transplantation for myelodysplasia and secondary acute nonlymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(10):1707-14.
1990: A M Neville; R Bettelheim; Richard D Gelber; A Goldhirsch
Occult axillary lymph-node micrometastases in breast cancer.
Lancet 1990;336(8717):759.
1990: A Goldhirsch; Rebecca Gelman; Richard D Gelber; M Castiglione
Treatment of breast cancer in elderly patients.
Lancet 1990;336(8714):564.
1990: J Richner; H A Gerber; G W Locher; Aron Goldhirsch; Richard D Gelber; W J Gullick; M S Berger; Bernd Groner; Nancy E Hynes
c-erbB-2 protein expression in node negative breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1990;1(4):263-8.
1990: A Goldhirsch; M Castiglione; Richard D Gelber
Adjuvant chemo-endocrine therapy in postmenopausal women with breast cancer and axillary-node metastases.
Lancet 1990;335(8697):1099-100.
1990: M Castiglione; Richard D Gelber; A Goldhirsch
Adjuvant systemic therapy for breast cancer in the elderly: competing causes of mortality. International Breast Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(3):519-26.
1990: D P Waber; D K Urion; Nancy J Tarbell; C Niemeyer; Richard D Gelber; Stephen E Sallan
Late effects of central nervous system treatment of acute lymphoblastic leukemia in childhood are sex-dependent.
Developmental medicine and child neurology 1990;32(3):238-48.
1990: Rebecca Gelman; Richard D Gelber; I C Henderson; C Norman Coleman; Jay R Harris
Improved methodology for analyzing local and distant recurrence.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(3):548-55.
1990: A Goldhirsch; Richard D Gelber; M Castiglione
The magnitude of endocrine effects of adjuvant chemotherapy for premenopausal breast cancer patients. The International Breast Cancer Study Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1990;1(3):183-8.
1990: Stephen E Sallan; Richard D Gelber; V Kimball; M Donnelly; H J Cohen
More is better! Update of Dana-Farber Cancer Institute/Children's Hospital childhood acute lymphoblastic leukemia trials.
Haematology and blood transfusion 1990;33():459-66.
1990: Holcombe E Grier; Richard D Gelber; L A Clavell; B M Camitta; Michael P Link; M J Garcea; Howard J Weinstein
Intensive sequential chemotherapy for children with acute myelogenous leukemia.
Haematology and blood transfusion 1990;33():193-7.
1989: Stephen E Sallan; C M Niemeyer; Amy L Billett; Jeffrey Lipton; Nancy J Tarbell; Richard D Gelber; C Murray; T P Pittinger; L C Wolfe; R C Bast
Autologous bone marrow transplantation for acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(11):1594-601.
1989: Jonathan A Fletcher; V M Kimball; E Lynch; M Donnelly; K Pavelka; Richard D Gelber; R Tantravahi; Stephen E Sallan
Prognostic implications of cytogenetic studies in an intensively treated group of children with acute lymphoblastic leukemia.
Blood 1989;74(6):2130-5.
1989: Richard D Gelber; R S Gelman; A Goldhirsch
A quality-of-life-oriented endpoint for comparing therapies.
Biometrics 1989;45(3):781-95.
1989: Richard D Gelber; A Goldhirsch
Clinical trials for clinicians.
Chest 1989;96(1 Suppl):97S-101S.
1989: Richard D Gelber; A Goldhirsch; M Castiglione
The duration of a life of quality should become the focus of "quality-of-life" studies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(4):542-4.
1989: Richard D Gelber; A Goldhirsch
Comparison of adjuvant therapies using quality-of-life considerations.
International journal of technology assessment in health care 1989;5(3):401-13.
1989: Aron Goldhirsch; Richard D Gelber
Randomized perioperative therapy in operable breast cancer: the Ludwig Trial V.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;115():43-53.
1989: Richard D Gelber; Aron Goldhirsch
Methods for assessing treatment efficacy in trials for adjuvant therapy for breast cancer.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;115():211-9.
1989: Aron Goldhirsch; Richard D Gelber
Adjuvant chemo-endocrine therapy or endocrine therapy alone for postmenopausal patients: Ludwig Studies III and IV.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;115():153-62.
1989: A Goldhirsch; Richard D Gelber; R John Simes; P Glasziou; A S Coates
Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(1):36-44.
1988: Gerald B Healy; Richard D Gelber; A L Trowbridge; K M Grundfast; Robert J Ruben; K N Price
Treatment of recurrent respiratory papillomatosis with human leukocyte interferon. Results of a multicenter randomized clinical trial.
The New England journal of medicine 1988;319(7):401-7.
1988: Richard D Gelber; A Goldhirsch
Can a clinical trial be the treatment of choice for patients with cancer?
Journal of the National Cancer Institute 1988;80(12):886-7.
1988: D L Hoover; L E Smith; S J Turner; Richard D Gelber; Stephen E Sallan
Ophthalmic evaluation of survivors of acute lymphoblastic leukemia.
Ophthalmology 1988;95(2):151-5.
1988: Richard D Gelber; A Goldhirsch
Meta-analysis in clinical research.
Annals of internal medicine 1988;108(1):158-9.
1988: A Goldhirsch; Richard D Gelber; M Castiglione
Relapse of breast cancer after adjuvant treatment in premenopausal and perimenopausal women: patterns and prognoses.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(1):89-97.
1987: David W Hedley; C A Rugg; Richard D Gelber
Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer.
Cancer research 1987;47(17):4729-35.
1987: S Kramer; Richard D Gelber; J B Snow; V A Marcial; L D Lowry; L W Davis; R Chandler
Combined radiation therapy and surgery in the management of advanced head and neck cancer: final report of study 73-03 of the Radiation Therapy Oncology Group.
Head & neck surgery 1987;10(1):19-30.
1987: A Goldhirsch; Richard D Gelber; M N Tattersall; C M Rudenstam; F Cavalli
Methotrexate/nitrous-oxide toxic interaction in perioperative chemotherapy for early breast cancer.
Lancet 1987;2(8551):151.
1987: Holcombe E Grier; Richard D Gelber; B M Camitta; M J Delorey; M P Link; K N Price; P R Leavitt; Howard J Weinstein
Prognostic factors in childhood acute myelogenous leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(7):1026-32.
1987: Richard D Gelber; A Goldhirsch
Interpretation of results from subset analyses within overviews of randomized clinical trials.
Statistics in medicine 1987;6(3):371-88.
1987: Frederick P Li; K Gimbrere; Richard D Gelber; Stephen E Sallan; F Flamant; D M Green; R Heyn; A T Meadows
Outcome of pregnancy in survivors of Wilms' tumor.
JAMA : the journal of the American Medical Association 1987;257(2):216-9.
1986: B W Davis; Richard D Gelber; Aron Goldhirsch; W H Hartmann; G W Locher; R Reed; Rastko Golouh; J Säve-Söderbergh; L Holloway; I Russell
Prognostic significance of tumor grade in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis.
Cancer 1986;58(12):2662-70.
1986: Richard D Gelber; A Goldhirsch
A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(12):1772-9.
1986: Richard D Gelber; A Goldhirsch
The concept of an overview of cancer clinical trials with special emphasis on early breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(11):1696-703.
1986: L A Clavell; Richard D Gelber; H J Cohen; S Hitchcock-Bryan; J R Cassady; Nancy J Tarbell; S R Blattner; R Tantravahi; P Leavitt; Stephen E Sallan
Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia.
The New England journal of medicine 1986;315(11):657-63.
1986: H N Himel; A Liberati; Richard D Gelber; T C Chalmers
Adjuvant chemotherapy for breast cancer. A pooled estimate based on published randomized control trials.
JAMA : the journal of the American Medical Association 1986;256(9):1148-59.
1986: A Pedrazzini; Richard D Gelber; M Isley; Monica Castiglione; Aron Goldhirsch
First repeated bone scan in the observation of patients with operable breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(3):389-94.
1986: A Goldhirsch; Richard D Gelber
Adjuvant treatment for early breast cancer: the Ludwig breast cancer studies.
NCI monographs : a publication of the National Cancer Institute 1986;(1):55-70.
1985: B W Davis; Richard D Gelber; A Goldhirsch; W H Hartmann; L Hollaway; I Russell; C M Rudenstam
Prognostic significance of peritumoral vessel invasion in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis.
Human pathology 1985;16(12):1212-8.
1985: A Goldhirsch; Richard D Gelber; F Cavalli; C M Rudenstam; M N Tattersall
Adjuvant therapy in postmenopausal node-positive breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1985;3(7):1045-7.
1985: A Goldhirsch; Richard D Gelber; M N Tattersall; C M Rudenstam; F Cavalli
Endocrine adjuvant therapy for breast cancer.
Lancet 1985;1(8440):1274.
1985: Allen M Goorin; B J Hershey; M J Levin; G R Siber; Richard D Gelber; K Flynn; M Lew; K Beckett; P Blanding; Stephen E Sallan
Use of trimethoprim-sulfamethoxazole to prevent bacterial infections in children with acute lymphoblastic leukemia.
Pediatric infectious disease 1985;4(3):265-9.
1985: C J Rominger; L L Gunderson; Richard D Gelber; N Conner
Radiation therapy alone or in combination with chemotherapy in the treatment of residual or inoperable carcinoma of the rectum and rectosigmoid or pelvic recurrence following colorectal surgery. Radiation Therapy Oncology Group study (76-16).
American journal of clinical oncology 1985;8(2):118-27.
1985: Richard D Gelber
Methodological and statistical aspects in perioperative chemotherapy trials.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1985;98():53-63.
1984: Allen M Goorin; M J Delorey; E E Lack; Richard D Gelber; K Price; J R Cassady; R Levey; D Tapper; N Jaffe; Michael Link
Prognostic significance of complete surgical resection of pulmonary metastases in patients with osteogenic sarcoma: analysis of 32 patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1984;2(5):425-31.
1984: Richard D Gelber
Ludwig Breast Cancer trial LBCS III: chemo- and endocrine adjuvant treatment in postmenopausal patients.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1984;96():102-9.
1983: Frederick P Li; J C Yan; Stephen E Sallan; J R Cassady; J Danahy; W Fine; Richard D Gelber; D M Green
Second neoplasms after Wilms' tumor in childhood.
Journal of the National Cancer Institute 1983;71(6):1205-9.
1982: S G Taylor; Richard D Gelber
Experience of the Eastern Cooperative Oncology Group with doxorubicin as a single agent in patients with previously untreated breast cancer.
Cancer treatment reports 1982;66(7):1594-5.